ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pharmachem australia pty ltd - piperazine citrate - oral solution/suspension - piperazine citrate amine/amide active 450.0 g/l - parasiticides - cage birds | pigeon | pigs | poultry | boar | breeders | broiler | chickens | chicks | chooks | day old chicks | doves | gilt | - nodule worm - oesophagostomun dentatum | roundworm - ascaridia columbae | roundworm - ascaridia galli | roundworm - ascaridia spp.

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inca (flight) co pty ltd - piperazine anhydrous - oral solution/suspension - piperazine anhydrous amine/amide active 172.5 g/l - parasiticides - pigeon | pigs | poultry | boar | breeders | broiler | chickens | chicks | chooks | day old chicks | doves | gilt | hatchlings | - large intestinal roundworm - a. suum | nodule worm - oesophagostomum spp. | roundworm - ascaridia columbae | roundworm - ascaridia galli | large roundworm

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - piperazine as piperazine dihydrochloride - oral powder, pre-mix - piperazine as piperazine dihydrochloride amine/amide active 530.0 mg/g - parasiticides - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - roundworm - ascaridia spp.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

rebel distributors corp - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil citrate 50 mg - consistent with its known effects on the nitric oxide/cgmp pathway (see clinical pharmacology ), viagra was shown to potentiate the hypotensive effects of nitrates, and its administration to patients who are using organic nitrates, either regularly and/or intermittently, in any form is therefore contraindicated. after patients have taken viagra, it is unknown when nitrates, if necessary, can be safely administered. based on the pharmacokinetic profile of a single 100 mg oral dose given to healthy normal volunteers, the plasma levels of sildenafil at 24 hours post dose are approximately 2 ng/ml (compared to peak plasma levels of approximately 440 ng/ml) (see clinical pharmacology: pharmacokinetics and metabolism ). in the following patients: age >65, hepatic impairment (e.g., cirrhosis), severe renal impairment (e.g., creatinine clearance less than 30 ml/min), and concomitant use of potent cytochrome p450 3a4 inhibitors (erythromycin), plasma levels of sildenafil at 24 hours post dose have been found to be

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

torrent pharmaceuticals limited - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - adults sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (pah) (world health organization [who] group i) in adults to improve exercise ability and delay clinical worsening [see clinical studies (14) ]. pediatric use information is approved for viatris specialty llc's, revatio (sildenafil) tablets. however, due to viatris specialty llc's marketing exclusivity rights, this drug product is not labeled with that information. sildenafil citrate is contraindicated in patients with: - concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions ( 5.1)] . - concomitant use of riociguat, a guanylate cyclase stimulator. phosphodiesterase-5 (pde5) inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat. - known hypersensitivity to sildenafil or any component of the tablet. hypersensitivity, including anaphylactic reaction, anaphylactic shock and anaphylactoid reaction, has been reported in association with the use of sildenafil. risk summary limited published data from randomized controlled trials, case-controlled trials, and case series do not report a clear association with sildenafil and major birth defects, miscarriage, or adverse maternal or fetal outcomes when sildenafil is used during pregnancy. there are risks to the mother and fetus from untreated pulmonary arterial hypertension (see clinical considerations ). animal reproduction studies conducted with sildenafil showed no evidence of embryo-fetal toxicity or teratogenicity at doses up to 32-and 65-times the recommended human dose (rhd) of 20 mg three times a day in rats and rabbits, respectively (see data ). the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical consideratio ns disease-associated maternal and/or embryo/fetal risk pregnant women with untreated pulmonary arterial hypertension are at risk for heart failure, stroke, preterm delivery, and maternal and fetal death. data animal data no evidence of teratogenicity, embryotoxicity, or fetotoxicity was observed in pregnant rats or rabbits dosed with sildenafil 200 mg/kg/day during organogenesis, a level that is, on a mg/m2 basis, 32-and 65-times, respectively, the recommended human dose (rhd) of 20 mg three times a day. in a rat pre-and postnatal development study, the no-observed-adverse-effect dose was 30 mg/kg/day (equivalent to 5-times the rhd on a mg/m2 basis). risk summary limited published data from a case report describe the presence of sildenafil and its active metabolite in human milk. there is insufficient information about the effects of sildenafil on the breastfed infant and no information on the effects of sildenafil on milk production. limited clinical data during lactation preclude a clear determination of the risk of sildenafil citrate to an infant during lactation. the safety and effectiveness of sildenafil citrate have not been established in pediatric patients younger than 1 year of age. pediatric use information is approved for viatris specialty llc's, revatio (sildenafil) tablets. however, due to viatris specialty llc's marketing exclusivity rights, this drug product is not labeled with that information. clinical studies of sildenafil citrate did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients. other reported clinical experience has not identified differences in responses between the elderly and younger patients. in general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy [see clinical pharmacology (12.3)] . no dose adjustment for mild to moderate impairment is required. severe impairment has not been studied [see clinical pharmacology (12.3)] . no dose adjustment is required (including severe impairment clcr <30 ml/min) [see clinical pharmacology (12.3)] .

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

vensun pharmaceuticals, inc. - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil tablets were added to background epoprostenol therapy [see clinical studies (14)]. studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii-iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use : adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14)]. sildenafil tablets are contraindicated in patients with: -   concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2)]. -   concomitant use of riociguat, a guanylate cyclase stimulator.

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - piperazine dihydrochloride - unknown - piperazine dihydrochloride amine/amide active 0.0 - active constituent

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pharmachem australia pty ltd - piperazine citrate - unknown - piperazine citrate amine/amide active 0.0 - active constituent

कनाडा - अंग्रेज़ी - Health Canada

dominion veterinary laboratories ltd. - piperazine dihydrochloride - powder - 99.9g - piperazine dihydrochloride 99.9g - swine (pigs); poultry; poultry; horses

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

united pet group - piperazine (unii: 1rtm4pal0v) (piperazine - unii:1rtm4pal0v) - piperazine 3 g in 7.5 g - effective against large roundworms (toxocara cati and toxascaris leonina)